Riddhi Siddhi Gluco Biols Q2 Results FY27: PAT Rises 26.92% to Rs 17.68 Cr, Revenue Rs 58.43 Cr
- November 6, 2026
- Posted by: Harsh Piplani
- Category: Results
Quick Answer
Riddhi Siddhi Gluco Biols Q2 Results FY27 were declared on 5 November 2026, with revenue of Rs 58.43 Cr against Rs 32.10 Cr in the same quarter last year. Net profit came in at Rs 17.68 Cr against Rs 13.93 Cr a year earlier. These quarterly results show YoY growth of 82.02% in revenue and 26.92% in net profit.
Riddhi Siddhi Gluco Biols Ltd (RIDDHI) Q2 Results FY27 announced on 5 November 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 58.43 Cr and PAT of Rs 17.68 Cr. The results date places Riddhi Siddhi Gluco Biols Q2 Results FY27 with both lines above the same quarter last year.
This Riddhi Siddhi Gluco Biols Q2 Results results analysis covers the financial highlights, business drivers, outlook and risks, using the figures filed with NSE and BSE. Readers on Univest can begin with the Financial Highlights, where revenue and net profit appear beside the same quarter last year. Each section hands over to the next, so the figures read as one connected story from revenue to risks.
Click Here – Get Free Investment Predictions
Riddhi Siddhi Gluco Biols Q2 Results FY27: Financial Highlights
| Metric | Q2 FY27 (Sep 26) | Q2 FY26 (Sep 25) | YoY Change |
|---|---|---|---|
| Revenue | Rs 58.43 Cr | Rs 32.1 Cr | +82.02% YoY |
| Net Profit (PAT) | Rs 17.68 Cr | Rs 13.93 Cr | +26.92% YoY |
Source: company filing for Riddhi Siddhi Gluco Biols Q2 Results FY27, 5 November 2026. Figures in Rs Crore.
Key Takeaways from Riddhi Siddhi Gluco Biols Q2 Results: What Stands Out
- Revenue of Rs 58.43 Cr rose from Rs 32.10 Cr in the same quarter last year, which is YoY growth of 82.02%.
- Net profit of Rs 17.68 Cr compares with Rs 13.93 Cr a year earlier, a 26.92% rise recorded in Riddhi Siddhi Gluco Biols Q2 Results FY27.
- Net profit was up 440.7% quarter on quarter from Rs 3.27 Cr, which is a second reference point beside the YoY comparison.
- Net profit margin of 30.3% narrowed from 43.4% in the comparison quarter, which is the main risk headline attached to this release.
- The performance analysis follows and sets revenue and net profit against each other in more detail.
Riddhi Siddhi Gluco Biols Q2 Results FY27: Performance Analysis
Both revenue and net profit were higher than in the same quarter last year. Revenue reached Rs 58.43 Cr against Rs 32.10 Cr, and net profit reached Rs 17.68 Cr against Rs 13.93 Cr, so the quarter closed with growth on each line. The year-ago quarter is the comparison base for every percentage in this release, and each one can be checked against the two supplied amounts shown in the Financial Highlights table.
On a YoY growth basis, revenue rose 82.02% and net profit rose 26.92%. Riddhi Siddhi Gluco Biols Q2 Results FY27 therefore shows revenue growing faster than net profit, a pattern that investors can verify directly from the two percentages in the Financial Highlights.
Across the quarterly results, net profit margin stood at 30.3% against 43.4% in the comparison quarter. For Riddhi Siddhi Gluco Biols Q2 Results, later filings will show whether this margin settles, which brings the results analysis to the business factors.
Check the Univest Screener for live results data
Key Business Factors This Quarter
Revenue Growth – The results analysis starts with revenue, which grew 82.0% year on year to Rs 58.43 Cr in the latest quarter. This is the first disclosed business factor, and the supplied data does not establish the specific cause.
Net Profit Rise – Net profit rose 26.9% year on year to Rs 17.68 Cr. In Riddhi Siddhi Gluco Biols Q2 Results FY27, this is the second disclosed factor, and it sits alongside the revenue gain within the same quarterly results.
Quarter on Quarter Net Profit – Net profit was up 440.7% quarter on quarter from Rs 3.27 Cr. The figures show the size of the sequential change, while the filing data does not name a driver, so none is assigned here.
FY27 Outlook After Riddhi Siddhi Gluco Biols Q2 Results
The FY27 outlook depends on what the coming quarters report. Riddhi Siddhi Gluco Biols Q2 Results FY27 covers only July to September 2026, so full-year FY27 results will depend on subsequent quarters and on disclosed sector conditions.
This results analysis keeps net profit in focus, since Rs 17.68 Cr is above the Rs 13.93 Cr of a year earlier and far above the Rs 3.27 Cr of the previous quarter. The Univest Screener can track later filings, which is also where the risks come into view. Reading the figures in order, the YoY gain, the sequential jump and the annual ratios each give a different time frame for the same company.
Key Risks to Watch After Riddhi Siddhi Gluco Biols Q2 Results FY27
Narrower Net Profit Margin
Net profit margin narrowed to 30.3% from 43.4% in the comparison quarter. After Riddhi Siddhi Gluco Biols Q2 Results FY27, this margin is the figure that investors will compare against every later quarterly filing.
Low Return on Equity
Return on equity was low at 1.33% in FY26. This annual ratio is separate from the quarterly net profit and covers a longer period than one quarter, which gives investors a different measure to read with the YoY growth in this release.
Modest Return on Capital
Return on capital employed was modest at 2.80% in FY26. Like return on equity, this annual figure sits beside the quarter’s revenue and net profit growth and shows how the full year compared with the latest quarter.
Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.
Conclusion
Riddhi Siddhi Gluco Biols Q2 Results FY27 show revenue of Rs 58.43 Cr and net profit of Rs 17.68 Cr. Both lines grew year on year, with revenue growing faster than net profit. In the wider quarterly results picture, Riddhi Siddhi Gluco Biols Q2 Results also carries a narrower margin that investors can track. The Financial Highlights table above and the risk sections give the full set of figures behind this summary. Investors should consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions on Riddhi Siddhi Gluco Biols Q2 Results FY27
What are Riddhi Siddhi Gluco Biols Q2 Results FY27?
Ans. These are the quarterly results declared by Riddhi Siddhi Gluco Biols for July to September 2026, showing revenue of Rs 58.43 Cr and net profit of Rs 17.68 Cr, as covered in the Quick Answer above.
What is the results date for Riddhi Siddhi Gluco Biols Q2 Results FY27?
Ans. Riddhi Siddhi Gluco Biols declared its Q2 results on 5 November 2026, so the figures cover July to September 2026, and the results date is also stated in the opening section of this article.
What revenue was reported in Riddhi Siddhi Gluco Biols Q2 Results FY27?
Ans. Riddhi Siddhi Gluco Biols reported revenue of Rs 58.43 Cr, compared with Rs 32.10 Cr in the same quarter last year, as shown in the Financial Highlights table.
What net profit was reported in Riddhi Siddhi Gluco Biols Q2 Results FY27?
Ans. Riddhi Siddhi Gluco Biols reported net profit of Rs 17.68 Cr, compared with Rs 13.93 Cr in the same quarter last year, which the Key Takeaways section lists alongside revenue.
How much YoY growth did revenue show in Riddhi Siddhi Gluco Biols Q2 Results FY27?
Ans. Revenue in Riddhi Siddhi Gluco Biols Q2 Results FY27 grew 82.02% year on year to Rs 58.43 Cr, which means the top line rose sharply, and the Performance Analysis section sets out the comparison.
Did net profit rise or fall in Riddhi Siddhi Gluco Biols Q2 Results?
Ans. Net profit rose 26.92% to Rs 17.68 Cr from Rs 13.93 Cr, so it grew more slowly than revenue year on year, as the Performance Analysis section explains.
What was the net profit YoY growth in Riddhi Siddhi Gluco Biols Q2 Results FY27?
Ans. Net profit YoY growth was 26.92%, compared with revenue YoY growth of 82.02%, which means revenue expanded at a faster rate, as listed under Key Business Factors.
What was the net profit margin in Riddhi Siddhi Gluco Biols Q2 Results?
Ans. Net profit margin was 30.3% in this quarter against 43.4% in the comparison quarter, which means margin narrowed even as profit grew, as the Key Risks section notes.
What business factors shaped Riddhi Siddhi Gluco Biols Q2 Results FY27?
Ans. The disclosed factors are revenue growth of 82.0% to Rs 58.43 Cr and a net profit rise of 26.9% to Rs 17.68 Cr, which the Key Business Factors section covers further.
What are the key risks after Riddhi Siddhi Gluco Biols Q2 Results FY27?
Ans. Risks include a net profit margin that narrowed to 30.3%, a return on equity of 1.33% and a return on capital employed of 2.80%, as detailed under Key Risks to Watch.
What is the outlook after Riddhi Siddhi Gluco Biols Q2 Results?
Ans. The FY27 outlook depends on subsequent quarters, since this filing covers only July to September 2026, so the FY27 Outlook section links the next filings to the net profit trend.
Where can I find the complete Riddhi Siddhi Gluco Biols Q2 Results FY27 data?
Ans. The full figures sit in the Financial Highlights table above, and the Univest app and Univest Screener can be used to follow the next Riddhi Siddhi Gluco Biols filings.
